The aim of the development of new anticancer drugs using micellar nanoparticles is to improve patients' Quality of Life (QOL), by increasing therapeutic efficacy of drugs which will lead to longer lifetime of patients and reduced cancer-related symptoms; by improving drug safety (reducing side effects); by decreasing patient burden by simple administrations which enable them to be outpatients; and by reducing medical expenses by possible day treatment etc.

Expected Benefits for Cancer Patients Improved EfficacyReduced Side Effects, Improved SafetyBetter Usability (possible day treatment etc.)Reduced Medical ExpensesImproved Quality of Life (QOL) of Cancer Patients